This week sees the launch of a pioneering chain of custody and transaction verification platform for the health sector that delivers absolute confidence and certainty to the user, provides real-time authentication and eliminates the risk of fraud. The DocuChain ‘Chain of Custody’ platform supports the validity of a wide-range of high-value transactions and mission critical processes, which will help health authorities, medical practioners and professional bodies benefit from assured provenance of documentation relating to patient treatment pathways, medical records, staff qualifications and pharmaceutical validation.
The Chain of Custody platform (patent pending) is called 4Trust and utilises a proprietary combination of technologies under license from DocuChain Limited. 4Trust incorporates a range of technologies from DocuChain and its constituent members: Uqudo (identity and access management), NXP (NFC integrated circuits), Qadre (Plug blockchain infrastructure) and Trotec (laser engraving specialist).
The TALL Group of Companies, the UK leader in the provision of secure paper and electronic payment solutions, is leading the launch of the 4Trust platform as the exclusive licensee in the UK and Ireland – and the founding member of DocuChain’s 4Trust Alliance, a global partnership of 4Trust licensees.
Organisations within the health sector using the 4Trust Chain of Custody platform will obtain a specially-crafted smart polymer document produced by the TALL Group, which provides the physical, tangible record of the transaction, whose provenance can be authenticated in an immutable, external blockchain record. The document, described as a SmartPolymer Artifact, incorporates sophisticated fraud prevention features such as laser engraved images, encrypted QR Codes and embedded intelligence in the form of NFC (near-field communications) integrated circuits, which link the certificate to the digital record of the transaction or entitlements in question held in blockchain. The provenance of the creation of both the Artifact and its related metadata (Assets and Activities including entitlements and privileges) are then stored securely in the 4Trust Chain of Custody. This correlation between the physical and digital records creates a singular “Chain of Custody” that can be validated in real-time using mobile and desktop applications that are downloadable with every Artifact produced.
Philip Leone, Founder and CEO of DocuChain, said: “Legacy chains of custody are flawed and certainly not trustworthy and the cost to organisations operating in the health sector are unacceptable and possibly life threatening! Our architecture provides four elements – two physical and two logical – which build upon existing document and trust systems, with authentications being conducted in real-time using Android, iOS and Windows apps. 4Trust’s innovative platform delivers and an immutable “Chain of Custody” for business performance, relationship management, governance, entitlement management and asset custodial services. Working with the TALL team has been very gratifying – they understand the dynamics and value of custody and how real time authentications engender trust, protect and value Identity, and restore sorely needed equities to global transaction domains.”
Martin Ruda, Group Managing Director of the TALL Group of Companies, said: “As the first licensee of the DocuChain Chain of Custody platform, the TALL Group will lead the UK’s health sector into a new era of indisputable provenance that can be authenticated in real-time, thereby helping health authorities and professionals to drive efficiency and achieve cost savings. We are extremely proud to have played a key role in the development of this important and ambitious solution, which we are sure will help to shape the future of how vital ownership and provenance information and records are stored and validated.
